drug research and development

Editorial: Alzheimer’s disease: original mechanisms and translational impact

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive andirreversible worsening of cognitive functions, inability to perform everyday activities, and mooddisorders. Currently, AD is considered the leading cause of dementia and hospitalization of olderadults in nursing homes. In the United States, 5.8 million people has been calculated to suffer fromAD in 2019, 81% being 75 years or older; the percentage of individuals with AD increases with age,from 3% of people aged 65–74 to 32% of people aged 85 and older.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma